BIOMERIEUX (BIM.PA) Stock Fundamental Analysis
Europe - EPA:BIM - FR0013280286 - Common Stock
113.6 EUR
+0.2 (+0.18%)
Taking everything into account, BIM scores 6 out of 10 in our fundamental rating. BIM was compared to 59 industry peers in the Health Care Equipment & Supplies industry. BIM has an excellent financial health rating, but there are some minor concerns on its profitability. BIM has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
BIM had positive earnings in the past year.
In the past year BIM had a positive cash flow from operations.
BIM had positive earnings in each of the past 5 years.
In the past 5 years BIM always reported a positive cash flow from operatings.
1.2 Ratios
BIM has a better Return On Assets (7.04%) than 77.97% of its industry peers.
BIM has a Return On Equity of 9.61%. This is in the better half of the industry: BIM outperforms 69.49% of its industry peers.
BIM has a Return On Invested Capital of 8.55%. This is in the better half of the industry: BIM outperforms 74.58% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BIM is in line with the industry average of 8.90%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.04% | ||
| ROE | 9.61% | ||
| ROIC | 8.55% |
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
1.3 Margins
With a decent Profit Margin value of 9.17%, BIM is doing good in the industry, outperforming 71.19% of the companies in the same industry.
BIM's Profit Margin has been stable in the last couple of years.
With a decent Operating Margin value of 12.37%, BIM is doing good in the industry, outperforming 62.71% of the companies in the same industry.
In the last couple of years the Operating Margin of BIM has grown nicely.
BIM's Gross Margin of 56.27% is in line compared to the rest of the industry. BIM outperforms 57.63% of its industry peers.
In the last couple of years the Gross Margin of BIM has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.37% | ||
| PM (TTM) | 9.17% | ||
| GM | 56.27% |
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BIM is still creating some value.
The number of shares outstanding for BIM remains at a similar level compared to 1 year ago.
Compared to 5 years ago, BIM has less shares outstanding
BIM has a better debt/assets ratio than last year.
2.2 Solvency
BIM has an Altman-Z score of 7.02. This indicates that BIM is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 7.02, BIM belongs to the best of the industry, outperforming 93.22% of the companies in the same industry.
BIM has a debt to FCF ratio of 1.15. This is a very positive value and a sign of high solvency as it would only need 1.15 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.15, BIM belongs to the top of the industry, outperforming 86.44% of the companies in the same industry.
BIM has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.09, BIM belongs to the top of the industry, outperforming 84.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 1.15 | ||
| Altman-Z | 7.02 |
ROIC/WACC1.11
WACC7.73%
2.3 Liquidity
BIM has a Current Ratio of 2.27. This indicates that BIM is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.27, BIM is in the better half of the industry, outperforming 66.10% of the companies in the same industry.
BIM has a Quick Ratio of 1.30. This is a normal value and indicates that BIM is financially healthy and should not expect problems in meeting its short term obligations.
BIM has a better Quick ratio (1.30) than 62.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.27 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
BIM shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.23%.
BIM shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.91% yearly.
The Revenue has grown by 8.28% in the past year. This is quite good.
Measured over the past years, BIM shows a quite strong growth in Revenue. The Revenue has been growing by 8.27% on average per year.
EPS 1Y (TTM)-8.23%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%
3.2 Future
BIM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.69% yearly.
The Revenue is expected to grow by 6.65% on average over the next years.
EPS Next Y18.23%
EPS Next 2Y15.22%
EPS Next 3Y14.58%
EPS Next 5Y13.69%
Revenue Next Year6.26%
Revenue Next 2Y6.57%
Revenue Next 3Y6.74%
Revenue Next 5Y6.65%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 29.43, the valuation of BIM can be described as expensive.
BIM's Price/Earnings ratio is a bit cheaper when compared to the industry. BIM is cheaper than 61.02% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.20. BIM is around the same levels.
The Price/Forward Earnings ratio is 22.17, which indicates a rather expensive current valuation of BIM.
BIM's Price/Forward Earnings is on the same level as the industry average.
BIM's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.71.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.43 | ||
| Fwd PE | 22.17 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BIM indicates a somewhat cheap valuation: BIM is cheaper than 67.80% of the companies listed in the same industry.
BIM's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BIM is cheaper than 69.49% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.6 | ||
| EV/EBITDA | 13.73 |
4.3 Compensation for Growth
BIM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of BIM may justify a higher PE ratio.
BIM's earnings are expected to grow with 14.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.61
PEG (5Y)2.7
EPS Next 2Y15.22%
EPS Next 3Y14.58%
5. Dividend
5.1 Amount
With a yearly dividend of 0.78%, BIM is not a good candidate for dividend investing.
BIM's Dividend Yield is comparable with the industry average which is at 2.30.
With a Dividend Yield of 0.78, BIM pays less dividend than the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.78% |
5.2 History
On average, the dividend of BIM grows each year by 19.40%, which is quite nice.
Dividend Growth(5Y)19.4%
Div Incr Years1
Div Non Decr Years7
5.3 Sustainability
28.08% of the earnings are spent on dividend by BIM. This is a low number and sustainable payout ratio.
BIM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.08%
EPS Next 2Y15.22%
EPS Next 3Y14.58%
EPA:BIM (9/17/2025, 5:35:15 PM)
113.6
+0.2 (+0.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners20.89%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap13.45B
Analysts73.33
Price Target127.89 (12.58%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.78% |
Yearly Dividend0.85
Dividend Growth(5Y)19.4%
DP28.08%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.31%
PT rev (3m)0.31%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.59%
EPS NY rev (3m)-1.59%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.17%
Revenue NY rev (3m)-0.96%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.43 | ||
| Fwd PE | 22.17 | ||
| P/S | 3.26 | ||
| P/FCF | 30.6 | ||
| P/OCF | 17.07 | ||
| P/B | 3.42 | ||
| P/tB | 4.81 | ||
| EV/EBITDA | 13.73 |
EPS(TTM)3.86
EY3.4%
EPS(NY)5.12
Fwd EY4.51%
FCF(TTM)3.71
FCFY3.27%
OCF(TTM)6.66
OCFY5.86%
SpS34.82
BVpS33.24
TBVpS23.61
PEG (NY)1.61
PEG (5Y)2.7
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.04% | ||
| ROE | 9.61% | ||
| ROCE | 11.69% | ||
| ROIC | 8.55% | ||
| ROICexc | 9.37% | ||
| ROICexgc | 13.09% | ||
| OM | 12.37% | ||
| PM (TTM) | 9.17% | ||
| GM | 56.27% | ||
| FCFM | 10.66% |
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
ROICexc(3y)11.26%
ROICexc(5y)13.92%
ROICexgc(3y)17.24%
ROICexgc(5y)22.12%
ROCE(3y)13.71%
ROCE(5y)16.2%
ROICexcg growth 3Y-22.62%
ROICexcg growth 5Y-8.16%
ROICexc growth 3Y-19.11%
ROICexc growth 5Y-1.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
F-Score8
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 1.15 | ||
| Debt/EBITDA | 0.36 | ||
| Cap/Depr | 73.33% | ||
| Cap/Sales | 8.45% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.99% | ||
| Profit Quality | 116.27% | ||
| Current Ratio | 2.27 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 7.02 |
F-Score8
WACC7.73%
ROIC/WACC1.11
Cap/Depr(3y)244.38%
Cap/Depr(5y)271.63%
Cap/Sales(3y)8.63%
Cap/Sales(5y)8.67%
Profit Quality(3y)48.66%
Profit Quality(5y)62.08%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.23%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
EPS Next Y18.23%
EPS Next 2Y15.22%
EPS Next 3Y14.58%
EPS Next 5Y13.69%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%
Revenue Next Year6.26%
Revenue Next 2Y6.57%
Revenue Next 3Y6.74%
Revenue Next 5Y6.65%
EBIT growth 1Y-1.89%
EBIT growth 3Y-7.95%
EBIT growth 5Y10.54%
EBIT Next Year61.98%
EBIT Next 3Y26.54%
EBIT Next 5Y19.41%
FCF growth 1Y133.85%
FCF growth 3Y-15.59%
FCF growth 5Y18.88%
OCF growth 1Y66.85%
OCF growth 3Y-6.82%
OCF growth 5Y10.35%